These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 32229609)
1. Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid Crisis. Weller AE; Crist RC; Reiner BC; Doyle GA; Berrettini WH Cold Spring Harb Perspect Med; 2021 Mar; 11(3):. PubMed ID: 32229609 [TBL] [Abstract][Full Text] [Related]
2. Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A Review. Kelty E; Preen DB CNS Drugs; 2019 Nov; 33(11):1113-1120. PubMed ID: 31686408 [TBL] [Abstract][Full Text] [Related]
3. Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality. Grossarth S; Osmundson SS; Wiese AD; Phillips SE; Pham A; Leech AA; Patrick SW; Spieker AJ; Grijalva CG; Adgent MA JAMA Pediatr; 2023 Jul; 177(7):675-683. PubMed ID: 37155175 [TBL] [Abstract][Full Text] [Related]
4. Maternal opioid use disorder and infant mortality in Wisconsin, United States, 2010-2018. Mallinson DC; Kuo HD; Kirby RS; Wang Y; Berger LM; Ehrenthal DB Prev Med; 2024 Apr; 181():107914. PubMed ID: 38408650 [TBL] [Abstract][Full Text] [Related]
5. Neonatal abstinence syndrome. Coyle MG; Brogly SB; Ahmed MS; Patrick SW; Jones HE Nat Rev Dis Primers; 2018 Nov; 4(1):47. PubMed ID: 30467370 [TBL] [Abstract][Full Text] [Related]
6. A Practical Approach to Neonatal Opiate Withdrawal Syndrome. Devlin LA; Davis JM Am J Perinatol; 2018 Mar; 35(4):324-330. PubMed ID: 29100261 [TBL] [Abstract][Full Text] [Related]
7. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age. Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024 [TBL] [Abstract][Full Text] [Related]
8. Maternal and iatrogenic neonatal opioid withdrawal syndrome: Differences and similarities in recognition, management, and consequences. Isaac L; van den Hoogen NJ; Habib S; Trang T J Neurosci Res; 2022 Jan; 100(1):373-395. PubMed ID: 33675100 [TBL] [Abstract][Full Text] [Related]
9. Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero. Lawlor ML; Shook LA; McQuerry K; Srinivasan A; Johnson QB; Chavan NR; Critchfield AS J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2718-2722. PubMed ID: 30563376 [No Abstract] [Full Text] [Related]
10. Maternal opioid use during pregnancy and the risk of neonatal opioid withdrawal syndrome in the offspring. Kristensen AW; Vestermark V; Kjærbye-Thygesen A; Eckhardt MC; Kesmodel US Acta Obstet Gynecol Scand; 2024 Aug; 103(8):1522-1529. PubMed ID: 38700023 [TBL] [Abstract][Full Text] [Related]
11. Association between Individual versus Community-level Social Vulnerability and Neonatal Opioid Withdrawal Syndrome among Pregnant Individuals Receiving Buprenorphine for Opioid Use Disorder. Mason I; Abdelwahab M; Stiles A; Wu J; Venkatesh KK; Rood KM Am J Perinatol; 2024 May; 41(S 01):e3157-e3163. PubMed ID: 37890511 [TBL] [Abstract][Full Text] [Related]
12. Severe Neonatal Opioid Withdrawal Requiring Pharmacotherapy: Impact of Region of Residence. Sankaran D; Rawat S; Kachelmeyer JL; Li ES; Reynolds AM; Rawat M; Chandrasekharan P Am J Perinatol; 2024 May; 41(S 01):e654-e663. PubMed ID: 35973797 [TBL] [Abstract][Full Text] [Related]
13. Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome. Singleton R; Rutz S; Day G; Hammes M; Wilson AS; Herrick M; Mazut C; Brunner L; Prince J; Desnoyers C; Shaw J; Hirschfeld M; Palis H; Slaunwhite A J Addict Med; 2022 Nov-Dec 01; 16(6):e366-e373. PubMed ID: 35245916 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns. Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312 [TBL] [Abstract][Full Text] [Related]
15. Duration and Timing of In Utero Opioid Exposure and Incidence of Neonatal Withdrawal Syndrome. Wang Y; Berger L; Durrance C; Kirby RS; Kuo D; Pac J; Ehrenthal DB Obstet Gynecol; 2023 Sep; 142(3):603-611. PubMed ID: 37548391 [TBL] [Abstract][Full Text] [Related]
16. Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol. Bryan MA; Smid MC; Cheng M; Fortenberry KT; Kenney A; Muniyappa B; Pendergrass D; Gordon AJ; Cochran G Addict Sci Clin Pract; 2020 Oct; 15(1):33. PubMed ID: 33129355 [TBL] [Abstract][Full Text] [Related]
17. The Time is NOW: Filling the Gaps in Treatment of Opioid-Exposed Infants: A Prospective, Pragmatic, Randomized Control Drug Trial. Czynski AJ; Laptook AR R I Med J (2013); 2021 Apr; 104(3):17-21. PubMed ID: 33789403 [TBL] [Abstract][Full Text] [Related]
18. Assessing Neonatal Opioid Withdrawal Syndrome Severity as a Function of Maternal Buprenorphine Dose and Umbilical Cord Tissue Concentrations. Rana D; McLeod AR; Gaston PK; Hill DM; Pourcyrous M Ann Pharmacother; 2023 Aug; 57(8):892-898. PubMed ID: 36321504 [TBL] [Abstract][Full Text] [Related]
20. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018. Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554 [No Abstract] [Full Text] [Related] [Next] [New Search]